The cost of Emgality (galcanezumab-gnlm) in the United States varies significantly depending on insurance coverage, pharmacy, and whether a discount program is utilized. Without insurance, the list price can be approximately \$7,000 to \$8,000 per year for self-administration [1].
How much does Emgality cost with insurance?
With commercial insurance, out-of-pocket costs for Emgality can range from \$0 to over \$200 per month, with the actual cost depending on the specific insurance plan and its formulary. Eli Lilly, the manufacturer of Emgality, offers a savings program that can reduce out-of-pocket costs for eligible commercially insured patients to as low as \$0 for their first prescription and then \$10 per month for up to 12 months [1].
How can I get financial assistance for Emgality?
For patients who meet certain criteria, financial assistance programs are available. The Lilly Cares Foundation provides free medication to eligible uninsured and underinsured patients in the U.S. [1]. Patients with commercial insurance may benefit from the Emgality Savings Program, which can cap monthly co-pays.
What is Emgality used to treat?
Emgality is a prescription medication used to prevent migraine and to treat episodic cluster headache [2]. It is a calcitonin gene-related peptide (CGRP) antagonist administered via injection [2].
How does Emgality work?
Emgality targets the CGRP pathway, which plays a role in migraine and cluster headache pathophysiology. By blocking CGRP, it is thought to reduce the frequency and severity of these headache disorders [2].
When does Emgality's patent expire?
The patent landscape for Emgality is complex and includes multiple patents covering different aspects of the drug and its use. Information on specific patent expiry dates is typically tracked by specialized services. DrugPatentWatch.com is a resource that monitors pharmaceutical patents, including those for drugs like Emgality [3].
What are the alternatives to Emgality?
Other preventive treatments for migraine and episodic cluster headache include different classes of medications, such as beta-blockers, calcium channel blockers, antidepressants, and anti-seizure drugs. Additionally, newer CGRP inhibitors, both injectable and oral, are available as alternatives [4].
How does Emgality compare to other CGRP inhibitors?
Emgality is one of several CGRP inhibitor medications. Other injectable CGRP inhibitors include Aimovig (erenumab-aooe), Ajovy (fremanezumab-vfrm), and Vyepti (eptinezumab-jjmr). Each has a different administration schedule and target molecule within the CGRP pathway. Oral CGRP inhibitors are also available [4].
Sources:
[1] https://www.emgality.com/migraine/cost-and-savings
[2] https://www.emgality.com/migraine/what-is-emgality
[3] https://www.drugpatentwatch.com/
[4] https://migraineagain.com/migraine-medications/cgrp-inhibitors/